iTeos Therapeutics (ITOS)
(Delayed Data from NSDQ)
$12.31 USD
-0.10 (-0.81%)
Updated May 7, 2024 04:00 PM ET
After-Market: $12.32 +0.01 (0.08%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth D Momentum F VGM
Brokerage Reports
0 items in cart
iTeos Therapeutics, Inc. [ITOS]
Reports for Purchase
Showing records 61 - 80 ( 108 total )
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
We are removing OPEN and WIX from the Best Ideas List due to our investment price discipline.
Provider: WEDBUSH SECURITIES INC.
Analyst: Research Department
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Adding ITOS to the Best Ideas List (BIL)
Provider: WEDBUSH SECURITIES INC.
Analyst: Research Department
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Increased Confidence in EOS-448s Success in NSCLC; Higher PT to $54; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
ASH 2021 Day 1 Roundup for Covered Companies
Provider: WEDBUSH SECURITIES INC.
Analyst: Research Department
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Increased Appreciation for ''448 After Viewing the CITYSCAPE
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Advancing Pipeline on all Fronts; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
An Undervalued Name With a Robust Balance Sheet; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
We Know Who''s on 1st, What''s on 2nd, but We Don''t Know ITOS''s 3rd Candidate
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
GSK Collaboration Validates EOS-448; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S